Introduction: Approximately 85% of patients who die from prostate cancer present the spread of bone metastases. Even though the radiological appearance of such metastases is osteoblastic, it is now ...

The ER-positive MCF-7 breast cancer cell line (ATCC HTB-22) was initially obtained in 1977 from the Michigan Cancer Foundation (Detroit, MI, USA). IBEP-2 cell line was previously established in our ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of women, NSAID use significantly decreased the efficacy of the bisphosphonate clodronate for ...

In terms of the duration of treatment, the patients studied by Powles showed a beneficial effect only while being treated and not after treatment was completed. This provides an argument for long-term ...

New research published in the Journal of Bone and Mineral Research suggests that non-steroidal anti-inflammatory drugs (NSAIDs) that are taken to reduce pain may block the beneficial effects of ...

September 26, 2011 (San Diego, California) — The use of bisphosphonates prior to a diagnosis of breast cancer appears to help prevent the development of bone metastases, which can result from the ...

SAN ANTONIO — A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the ...

Lower Dosing Regimens Of Bisphosphonates Show Antitumor Effects In Mice. ScienceDaily. Retrieved May 24, 2026 from www.sciencedaily.com / releases / 2007 / 02 / 070221092856.htm Journal of the ...

Nonsteroidal anti-inflammatory drugs (NSAIDs) seemed to neutralize the protective benefit of a certain bisphosphonate, according to a post-hoc analysis of a randomized controlled trial. Among over ...

Bisphosphonates are medications that used to treat bone loss and are the most common agent to be prescribed for osteoporosis. These drugs can also reduce fracture risk in cases of previous fracture.

Denosumab is a different type of medicine. It's a type of bone targeted treatment called a monoclonal antibody. You might have this as a treatment for cancer that has spread to the bones. It helps to ...

A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of ...